Kashiwa 277-8577
Japan
Nagoya
National Cancer Center, Japan - Division of Cancer Immunotherapy
Aichi Cancer Center - Division of Immunology
Cancer immunotherapy, iPS cell, type I interferon, XCR1, dendritic cells, cross-presentation, checkpoint blockade, PD-1, STING, CXCR3